Frequent Involvement of the Optic Radiation in Patients with Acute Isolated Optic Neuritis
Neurol 42:77-79, Hornabrook,R.S.L.,et al, 1992
Optic Neuritis:A Prospective Study
Neurol 40:919-923, Celesia,G.G.,et al, 1990
Evoked Potentials In Clinical Medicine, (First of Two Parts)
NEJM 306:1140-1150, Chiappa,K.H.,et al, 1982
Pattern Visual Evoked Responses in Multiple Sclerosis
Arch Neurol 34:314, Zeese,J.A., 1977
Subclinical Optic Neuropathy in Multiple Sclerosis
Arch Neurol 34:666, Galvin,R.J.,et al, 1977
A Man Who Lost Weight and His Sight
Lancet 351:1174-1175, Moschos,M.&Droutsas,D., 1998
Visual System Abnormalities in Adrenomyeloneuropathy
Ann Neurol 37:550-552, Kaplan,P.W.,et al, 1995
Intra-arterial Cisplatin-Associated Optic and Otic Toxicity
Arch Neurol 49:83-86, Maiese,K.,et al, 1992
Reversal of a Neurologic Paraneoplastic Syndrome with Octreotide (Sandostatin) in a Pt with Glucagonoma
Am J Med 91:434-436, Holmes,A.,et al, 1991
Vision and Hearing During Deferoxamine Therapy
J Pediatr 117:326-330, Cohen,A.,et al, 1990
Neurosarcoidosis:Signs, Course and Treatment in 35 Confirmed Cases
Medicine 69:261-276, Chapelon,C.,et al, 1990
Cortical Blindness:Etiology, Diagnosis, & Prognosis
Ann Neurol 21:149-158, Aldrich,M.S.,et al, 1987
Visual & Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine Infusions
NEJM 314:869-873, Olivieri,N.F.,et al, 1986
Leber's Optic Neuropathy
Editorial, BMJ 280:1097-10981980., , 1980
Clinical Pathological Conference
Adrenoleukodystrophy, with Peripheral Neuropathy, Case Record 18-1979, NEJM 300:1037-104579., , 1979
Toluene Optic Neuropathy
Ann Neurol 4:390, Keane,J.R., 1978